Luc Djoussé1, J Michael Gaziano, Julie E Buring, I-Min Lee. 1. Division of Aging and Preventive Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. ldjousse@rics.bwh.harvard.edu
Abstract
BACKGROUND: Although dietary omega-3 (n-3) fatty acids may confer some cardiovascular benefits, it is unclear whether these nutrients may also unfavorably affect risk of type 2 diabetes (T2D). OBJECTIVE: We evaluated whether dietary omega-3 fatty acids and fish consumption were associated with increased risk of T2D. DESIGN: This was a prospective study of 36,328 women (mean age: 54.6 y) who participated in the Women's Health Study and who were followed from 1992 to 2008. Incident T2D was self-reported and validated primarily through the collection of supplementary information from participants. Information on omega-3 and fish intakes was obtained by using a validated food-frequency questionnaire. We used Cox proportional hazard models to estimate adjusted relative risks. RESULTS: During an average follow-up of 12.4 y, 2370 women developed T2D. Marine but not plant-based omega-3 fatty acids were positively associated with incident T2D. From the lowest to highest quintiles of marine omega-3 intake, the multivariable-adjusted hazard ratios (95% CIs) for T2D were 1.0 (referent), 1.17 (1.03, 1.33), 1.20 (1.05, 1.38), 1.46 (1.28, 1.66), and 1.44 (1.25, 1.65), respectively (P for trend < 0.0001). A similar association was observed with fish intake, but additional adjustment for docosahexaenoic acid led to the elimination of the association. The relation between marine omega-3 fatty acids and T2D was observed in hypertensive and nonhypertensive subjects and in women who reported infrequent fish consumption. CONCLUSION: Our data suggest an increased risk of T2D with the intake of long-chain omega-3 fatty acids, especially with higher intakes (≥ 0.20 g omega-3/d or ≥ 2 servings of fish/d). The Women's Health Study was registered at clinicaltrials.gov as NCT00000479.
RCT Entities:
BACKGROUND: Although dietary omega-3 (n-3) fatty acids may confer some cardiovascular benefits, it is unclear whether these nutrients may also unfavorably affect risk of type 2 diabetes (T2D). OBJECTIVE: We evaluated whether dietary omega-3 fatty acids and fish consumption were associated with increased risk of T2D. DESIGN: This was a prospective study of 36,328 women (mean age: 54.6 y) who participated in the Women's Health Study and who were followed from 1992 to 2008. Incident T2D was self-reported and validated primarily through the collection of supplementary information from participants. Information on omega-3 and fish intakes was obtained by using a validated food-frequency questionnaire. We used Cox proportional hazard models to estimate adjusted relative risks. RESULTS: During an average follow-up of 12.4 y, 2370 women developed T2D. Marine but not plant-based omega-3 fatty acids were positively associated with incident T2D. From the lowest to highest quintiles of marine omega-3 intake, the multivariable-adjusted hazard ratios (95% CIs) for T2D were 1.0 (referent), 1.17 (1.03, 1.33), 1.20 (1.05, 1.38), 1.46 (1.28, 1.66), and 1.44 (1.25, 1.65), respectively (P for trend < 0.0001). A similar association was observed with fish intake, but additional adjustment for docosahexaenoic acid led to the elimination of the association. The relation between marine omega-3 fatty acids and T2D was observed in hypertensive and nonhypertensive subjects and in women who reported infrequent fish consumption. CONCLUSION: Our data suggest an increased risk of T2D with the intake of long-chain omega-3 fatty acids, especially with higher intakes (≥ 0.20 g omega-3/d or ≥ 2 servings of fish/d). The Women's Health Study was registered at clinicaltrials.gov as NCT00000479.
Authors: I-Min Lee; Nancy R Cook; J Michael Gaziano; David Gordon; Paul M Ridker; Joann E Manson; Charles H Hennekens; Julie E Buring Journal: JAMA Date: 2005-07-06 Impact factor: 56.272
Authors: Nancy R Cook; I-Min Lee; J Michael Gaziano; David Gordon; Paul M Ridker; JoAnn E Manson; Charles H Hennekens; Julie E Buring Journal: JAMA Date: 2005-07-06 Impact factor: 56.272
Authors: Luc Djoussé; Donna K Arnett; J Jeffrey Carr; John H Eckfeldt; Paul N Hopkins; Michael A Province; R Curtis Ellison Journal: Circulation Date: 2005-05-31 Impact factor: 29.690
Authors: Luc Djoussé; Steven C Hunt; Weihong Tang; John H Eckfeldt; Michael A Province; R Curtis Ellison Journal: Obesity (Silver Spring) Date: 2006-02 Impact factor: 5.002
Authors: Christine M Albert; Hannia Campos; Meir J Stampfer; Paul M Ridker; JoAnn E Manson; Walter C Willett; Jing Ma Journal: N Engl J Med Date: 2002-04-11 Impact factor: 91.245
Authors: Paul M Ridker; Nancy R Cook; I-Min Lee; David Gordon; J Michael Gaziano; Joann E Manson; Charles H Hennekens; Julie E Buring Journal: N Engl J Med Date: 2005-03-07 Impact factor: 91.245
Authors: Jason H Y Wu; Renata Micha; Fumiaki Imamura; An Pan; Mary L Biggs; Owais Ajaz; Luc Djousse; Frank B Hu; Dariush Mozaffarian Journal: Br J Nutr Date: 2012-06 Impact factor: 3.718
Authors: Ju-Sheng Zheng; Donna K Arnett; Laurence D Parnell; Yu-Chi Lee; Yiyi Ma; Caren E Smith; Kris Richardson; Duo Li; Ingrid B Borecki; Jose M Ordovas; Katherine L Tucker; Chao-Qiang Lai Journal: J Nutr Date: 2013-01-09 Impact factor: 4.798
Authors: Yong-Seok Kim; Pengcheng Xun; Carlos Iribarren; Linda Van Horn; Lyn Steffen; Martha L Daviglus; David Siscovick; Kiang Liu; Ka He Journal: Eur J Nutr Date: 2016-01-27 Impact factor: 5.614